• Panacea Global, Inc. (PGI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. Panacea’s novel product is a blood test that can detect the presence of cancer in humans using a novel cancer biomarker named Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH), an enzyme which is over expressed in cancer cells and is the foundation of our breakthrough technology.

Stock Quotes

PANG0.70  chart+0.02

The company’s lead program is to provide accurate, timely, cost effective and non-invasive testing across the globe to increase the quality of life of patients and ultimately saving lives.

Our vision is to have our diagnostics be affordable and accessible worldwide, and to provide accurate diagnostics for all forms of cancer.

Latest News